| Title: | Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology |
| Authors: | Lin, XZ Onda, DA Yang, CH Lewis, JR Levinger, I Loh, K |
| Issue Year: | 2020 |
| Publisher | ELSEVIER |
| Series | MOLECULAR METABOLISM: |
| Abstract | Acute myeloid leukemia (AML) is an aggressive, often fatal hematopoietic malignancy.All-transretinoic acid (atRA), one of the first molecularly targeted drugs in oncology, has greatly improved the outcome of a subtype of AML, acute promyelocytic leukemia (APL). In contrast, atRA has so far provided little therapeutic benefit in the much larger group of patients with non-APL AML. Attempts to identify genetically or molecularly defined subgroups of patients that may respond to atRA have not yielded consistent results. Since AML is a stem cell-driven disease, understanding the effectiveness of atRA may require an appreciation of its impact on AML stem cells. Recent studies reported that atRA decreased stemness of AML with anFLT3-ITD mutation, yet increased it inAML1-ETOdriven orEVI1-overexpressing AML. This review summarizes the role of atRA in normal hematopoiesis and in AML, focusing on its impact on AML stem cells. |
| URI: | https://publications.svi.edu.au/publications/7022 |
| Other Identifiers | 10.1016/j.molmet.2020.101040 |
| Publication type | Review |